Rajkumar Ganesan is currently the Vice President of Biotherapeutics at Third Arc Bio, leading an Antibody Engineering team. With extensive industry experience, Rajkumar has held senior roles at notable organizations such as Alector, Boehringer Ingelheim, and The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on the development of biotherapeutics, including monoclonal antibodies and multi-specific biologics. They earned a PhD in Biochemistry from the University of Zurich and have authored over 30 peer-reviewed papers and patents. Rajkumar's strong interpersonal skills and ability to work collaboratively have contributed significantly to their success in the field.
This person is not in any teams
This person is not in any offices